Jadenu
Blood Transfusions, Non-transfusion Dependent Thalassemia, Iron Overload
Treatment
2 Active Studies for Jadenu
Treatment for
Blood Transfusions
What is Jadenu
Deferasirox
The Generic name of this drug
Treatment Summary
Deferasirox is a prescription drug used to help reduce the amount of excess iron in the body. It is the first oral medication approved by the FDA for treating people who receive long-term blood transfusions.
Exjade
is the brand name
Jadenu Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Exjade
Deferasirox
2005
112
Effectiveness
How Jadenu Affects Patients
Deferasirox is a pill that binds to iron in the body. It is highly effective at grabbing onto iron, and also has some effect on zinc and copper. However, it is unclear if these decreases in trace metals have any important effects on the body.
How Jadenu works in the body
Deferasirox is effective at treating iron toxicity. It works by binding to iron atoms and forming a stable complex. This complex is then removed from the body via the kidneys.
When to interrupt dosage
The portion of Jadenu is contingent upon the perceived affliction, including Iron Overload, Blood Transfusions and Non-transfusion Dependent Thalassemia. The measure of dosage additionally differs as indicated by the method of administration (e.g. Granule or Tablet, film coated) featured in the table underneath.
Condition
Dosage
Administration
Iron Overload
125.0 mg, , 250.0 mg, 500.0 mg, 90.0 mg, 180.0 mg, 360.0 mg
Oral, , Tablet, for suspension - Oral, Tablet, for suspension, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Granule, Granule - Oral, Tablet, coated, Tablet, coated - Oral
Blood Transfusions
125.0 mg, , 250.0 mg, 500.0 mg, 90.0 mg, 180.0 mg, 360.0 mg
Oral, , Tablet, for suspension - Oral, Tablet, for suspension, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Granule, Granule - Oral, Tablet, coated, Tablet, coated - Oral
Non-transfusion Dependent Thalassemia
125.0 mg, , 250.0 mg, 500.0 mg, 90.0 mg, 180.0 mg, 360.0 mg
Oral, , Tablet, for suspension - Oral, Tablet, for suspension, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Granule, Granule - Oral, Tablet, coated, Tablet, coated - Oral
Warnings
Jadenu has four contraindications. When encountering any of the conditions in the given table, Jadenu should not be administered.
Jadenu Contraindications
Condition
Risk Level
Notes
Advanced Malignancies
Do Not Combine
Myelodysplastic Syndromes
Do Not Combine
Poor Performance Status
Do Not Combine
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Jadenu.
Common Jadenu Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Deferasirox.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be increased when combined with Deferasirox.
Alectinib
Major
The metabolism of Alectinib can be increased when combined with Deferasirox.
Alpelisib
Major
The metabolism of Alpelisib can be increased when combined with Deferasirox.
Amiodarone
Major
The metabolism of Amiodarone can be increased when combined with Deferasirox.
Jadenu Novel Uses: Which Conditions Have a Clinical Trial Featuring Jadenu?
Currently, there are no active studies assessing the effectiveness of Jadenu in providing Blood Transfusions, Non-transfusion Dependent Thalassemia and Iron Overload relief.
Condition
Clinical Trials
Trial Phases
Blood Transfusions
3 Actively Recruiting
Not Applicable
Iron Overload
0 Actively Recruiting
Non-transfusion Dependent Thalassemia
0 Actively Recruiting
Jadenu Reviews: What are patients saying about Jadenu?
4
Patient Review
11/19/2019
Jadenu for excess iron due to repeated blood transfusions
3.7
Patient Review
5/15/2016
Jadenu for Too Much Iron in the Blood for a Long Period of Time
2
Patient Review
10/12/2018
Jadenu for excess iron in person with non-transfusion-dependent thalassemia (NTDT)
2
Patient Review
8/5/2016
Jadenu for Too Much Iron in the Blood for a Long Period of Time
Patient Q&A Section about jadenu
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What type of drug is JADENU?
"Jadenu is a prescription medicine used to treat the symptoms of iron overload caused by Transfusional Hemosiderosis and Nontransfusion-Dependent Thalassemia. Jadenu may be used alone or with other medications. Jadenu helps to remove excess iron from the body by binding to it and allowing it to be passed out of the body in urine or stool. Jadenu belongs to a class of drugs called Chelators."
Answered by AI
What is JADENU prescribed for?
"JADENU is a prescription medication used to treat chronic iron buildup in people aged 2 and up who have received multiple blood transfusions."
Answered by AI
How long does it take JADENU to work?
"The treatment usually takes several months, during which time JADENU will help remove excess iron from your body to protect your heart and liver."
Answered by AI
Is there a generic for JADENU?
"The drug Deferasirox is available in various forms, including tablets and granules of different strengths, as well as a generic form for oral suspension."
Answered by AI